Morgan Stanley 13D and 13G filings for Tarsus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-07 11:27 am Sale | 2025-03-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | MORGAN STANLEY MS | 1,943,453 4.700% | -252 (-0.01%) | Filing |
| 2024-02-09 10:06 am Purchase | 2023-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | MORGAN STANLEY MS | 1,943,705 5.900% | 1,943,705 (New Position) | Filing |